丙胺卡因
Prilocaine;l67;Citanest;astra1515;astra1512;NSC 40027;Propitocaine;Prilocaine Base;Pricocaine;(±)-2′-Methyl-2-(propylamino)propionanilide;N-(2-Methylphenyl)-2-(propylamino)propanamide;N-(2-Methylphenyl)-2-propylamino-propanamide;PRILOCAINE [MI];SDCCGSBI-0050978.P004;N-(2-methylphenyl)-N2-propylalaninamide;Astra 1512;s1619;Spectrum3_001052;BPBio1_000173;L-67;EINECS 211-957-0;EN300-188120;Prilocainum [INN-Latin];CCG-205085;Prilocaina;Prilocaine (USP/INN);o-Methyl-alpha-propylaminopropionanilide;NCGC00015860-02;PRILOCAINE [WHO-DD];KBio3_001824;SBI-0050978.P003;KBio2_007265;DTXCID5011955;ORAQIX COMPONENT PRILOCAINE;PRILOCAINE COMPONENT OF FORTACIN;PRILOCAINE [INN];PRILOCAINE [VANDF];BRD-A53952395-003-15-2;AB00053665;MVFGUOIZUNYYSO-UHFFFAOYSA-N;Spectrum2_001549;2-(Propylamino)-o-propionotoluidide;N-(2,6-DIMETHYLPHENYL)-2-(PROPYLAMINO)PROPANAMIDE;L 67;GTPL7276;Prilocain;Q-100809;AB00053665-12;NCGC00162312-01;Propitocaine (JAN);ASTRA-1515;DTXSID7031955;2-(propylamino)-N-o-tolylpropanamide;DivK1c_000846;C07531;ASTRA-1512;SPBio_001398;HMS3604H09;AKOS015889404;Prilocaine (USAN:USP:INN:BAN);Prilocaina [INN-Spanish];KBioSS_002129;FORTACIN COMPONENT PRILOCAINE;Propranamide, N-(2-methylphenyl)-2-(propylamino)-;o-Propionotoluidide, 2-(propylamino)-;Prestwick2_000199;Lopac0_001005;alpha-n-Propylamino-2-methylpropionanilide;Spectrum4_001192;BSPBio_000157;AB00053665_14;Prilocainum (INN-Latin);SCHEMBL25467;AC-2100;prilocaine base;2-Methyl-alpha-propylaminopropionanilide;.alpha.-n-Propyl-amino-2-methylpropionanilide;Z44530398;CHEBI:8404;BSPBio_002604;PRILOCAINE COMPONENT OF ORAQIX;721-50-6;N01BB04;Prestwick0_000199;N-(2-methylphenyl)-N(2)-propylalaninamide;PRILOCAINE [USP-RS];2-(Propylamino)-N-(o-tolyl)propanamide;PRILOCAINE (USP MONOGRAPH);KBio1_000846;MFCD00048681;(.+/-.)-Prilocaine;KBio2_004697;o-Methyl-2-propylaminopropionanilide;o-Propionotuluidide, 2-propylamino-;o-Propionotoluidide, 2-propylamino-;DL-(+/-)-PRILOCAINE;Prilotekal;PRILOCAINE COMPONENT OF EMLA;Prilocainum;PRILOCAINE [HSDB];(+/-)-Prilocaine;NCGC00015860-03;AB00053665_13;046O35D44R;prilocaine;Q413598;HMS3884A04;UNII-046O35D44R;CHEMBL1194;EMLA COMPONENT PRILOCAINE;PRILOCAINE [USP MONOGRAPH];Spectrum5_001175;Prilocaine [USAN:USP:INN:BAN];KBioGR_001883;BDBM50225477;IDI1_000846;A837435;Prestwick1_000199;PRILOCAINE [ORANGE BOOK];N-(2-methylphenyl)-2-(propylamino)propanimidic acid;Spectrum_001649;FT-0660568;NSC-40027;KBio2_002129;(+/-)-N-(2-PROPYLAMINOPROPIONYL)-2-TOLUIDINE;NCGC00015860-15;Propanamide, N-(2-methylphenyl)-2-(propylamino)-;PRILOCAINE (EP MONOGRAPH);FT-0603506;2-Methyl-.alpha.-propylaminopropionanilide;HMS3651M13;NSC40027;Prestwick3_000199;NS00000546;PRILOCAINE (MART.);DB00750;N-(2-Methylphenyl)-2-(propylamino)propanamide #;BRN 2108498;PROPITOCAINE [JAN];PRILOCAINE (USP-RS);Astra 1515;Prilocaine [USAN];HSDB 3386;NINDS_000846;CS-1929;HY-B0137;PRILOCAINE [MART.];BRD-A5395239...